Medtronic announced that the FDA has approved its Inceptiv closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain.

Inceptiv offers a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time. Traditional fixed-output SCS devices deliver constant, mild electrical impulses that disrupt pain signals before they reach the brain, Medtronic explained in its announcement.

The Inceptiv SCS allows the option of multiple types of waveforms, including Medtronic’s proprietary Differential Target Multiplexed SCS therapy, which demonstrated an 84 percent responder rate at 12 months in a large, multicenter randomized controlled trial.

To read the whole story, click here.

Related Topics